• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Insurers want MLR policies to include anti-fraud efforts


One of the more popular strategies in Washington for reducing healthcare spending is to uncover fraudulent operators who bilk Medicare

For public and private payers together, the National Health Care Anti-Fraud Association (NHCAA) calculates that fraud costs the system between $75 billion and $250 billion a year.

Even more damaging is the harm to patients, NHCAA Executive Director Louis Saccoccio told the House Ways & Means Committee. Individuals often fail to get needed care or may receive harmful or unnecessary treatment from providers looking to overcharge healthcare systems.

Yet the payoff so far is just the "tip of the iceberg," say the legislators and prosecutors. And organized crime appears to be moving into healthcare fraud, attracted by the large volume of spending on healthcare and the ease of bilking the system.

Related Content
© 2024 MJH Life Sciences

All rights reserved.